Caprisa
Business Services · South Africa · 201-500 Employees
View Company Info for Free
Overview
Headquarters
719 Umbilo Rd, Durban, KwaZulu-Natal, 40...Phone Number
+27 312604555Website
www.caprisa.orgRevenue
$57.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Caprisa
CAPRISA, established in 2002, is a not-for-profit AIDS research organization based in South Africa, formed by five partner institutions including the University of KwaZulu-Natal and Columbia University. The organization specializes in various fields such as epidemiology, virology, immunology, and health policy, focusing on HIV prevention, treatment research, and vaccine development. CAPRISA aims to impact health through innovative research and community outreach initiatives. Their intended clients include researchers, healthcare professionals, and communities affected by HIV/AIDS.Explore more
Caprisa Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Caprisa your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Caprisa launches new products
Check out if Caprisa is spiking on competitors!
Click to see if Caprisa had a recent Job posting/layoffs
Caprisa, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Caprisa has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Caprisa has new funding data
Earning: See what the market has to say on Caprisa recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Caprisa
Recommended Actions
Find VP level buyers at Caprisa
Find 3 more new buyers
Company Profile Activity
Activity Insights
Caprisa is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Caprisa is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Caprisa.
Caprisa Tech Stack
A closer look at the technologies used by Caprisa
Most Recent Scoops
Hiring Plans
Caprisa has more open roles in Information Technology than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Caprisa has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Caprisa has more open roles in Finance than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Caprisa has more open roles in Quality Management than it has had at any time in the past 12 months.
Open Position
Caprisa News & Media
CAPRISA et Evotec lancent un nouveau projet visant l'accélération de la nouvelle technologie de prévention du VIH
KIGALI, Rwanda--(BUSINESS WIRE)--Aujourd'hui, lors d'une réunion organisée en marge du Sommet ministériel UE-Union africaine qui s'est tenu à Kigali, au Rwanda, le Professeur Salim Abdool Karim, directeur du CAPRISA, annonce une collaboration avec la société de premier plan dans le secteur des sciences de la vie, Evotec, en vue de la conception et du développement de CAP256, un anticorps neutralisant général contre le VIH. Le projet constitue une expansion majeure du développement de l'anticorpCAPRISA en Evotec lanceren een nieuw project om nieuwe technologie voor hiv-preventie versneld in te voeren
KIGALI, Rwanda--(BUSINESS WIRE)--Vandaag, tijdens een vergadering in de marge van de ministeriële AU-EU-top in Kigali, Rwanda, kondigde Prof. Salim Abdool Karim, directeur van CAPRISA, een samenwerking aan met het toonaangevende biowetenschappelijke bedrijf Evotec voor het ontwerpen en ontwikkelen van CAP256, een breed neutraliserend antilichaam tegen hiv. Het project is een belangrijke uitbreiding van de ontwikkeling van een antilichaam dat oorspronkelijk gezamenlijk werd ontwikkeld door CAPRICAPRISA und Evotec starten neues Projekt zur schnellen Entwicklung einer neuen Technologie zur HIV-Prävention
KIGALI, Ruanda--(BUSINESS WIRE)--Heute gab Prof. Salim Abdool Karim, Direktor des CAPRISA, bei einem Treffen am Rande der AU-EU-Ministerkonferenz in Kigali, Ruanda, eine Kooperation mit dem führenden Biowissenschaftsunternehmen Evotec für die Konzeption und Entwicklung von CAP256, einem breit neutralisierenden Antikörper gegen HIV, bekannt. Das Projekt stellt eine wichtige Ergänzung bei der Entwicklung eines Antikörpers dar, der ursprünglich gemeinsam von CAPRISA und dem Vaccine Research CenterCAPRISA e Evotec lanciano un nuovo progetto per accelerare una nuova tecnologia per la prevenzione dell'HIV
KIGALI, Ruanda--(BUSINESS WIRE)--Oggi, in un incontro collaterale durante il vertice ministeriale UA-UE a Kigali, Rwanda, il Prof Salim Abdool Karim, direttore di CAPRISA, ha annunciato una collaborazione con un'azienda leader nel settore delle scienze biologiche Evotec per la progettazione e lo sviluppo di CAP256, un anticorpo ampiamente neutralizzante contro l'HIV. Il progetto è un'importante espansione dello sviluppo di un anticorpo originariamente sviluppato congiuntamente da CAPRISA e dal
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Caprisa
Sign Up For FreeTo access detailed company insights
CAPRISA, established in 2002, is a not-for-profit AIDS research organization based in South Africa, formed by five partner institutions including the University of KwaZulu-Natal and Columbia University. The organization specializes in various fields such as epidemiology, virology, immunology, and health policy, focusing on HIV prevention, treatment... Read More
